DIANTHUS THERAPEUTICS INC (DNTH) Institutional Shareholders

DIANTHUS THERAPEUTICS INC (DNTH) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $5.72B in DNTH holdings during the latest filing period.

Fmr Llc is currently the largest disclosed institutional shareholder of DNTH tracked by InsiderSet, reporting ownership valued at approximately $799.33M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $898.71M, representing an estimated gain of +12.43% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 49% of the total disclosed DNTH value among the investors covered in this analysis. Major shareholders include Fmr Llc, Blackrock, Inc., State Street Corp, and several other long-term asset managers with concentrated positions in DIANTHUS THERAPEUTICS INC (DNTH).

This page ranks the largest institutional DNTH shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

267

Total Reported Value

$5.72B

Largest Holder

Fmr Llc

Largest Position

$799.33M

Insider Transactions (90d)

42

Latest Filing Quarter

Q2 2026

New Institutional Positions

89

Funds Exiting Positions

0

Page 1 of 6
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Fmr Llc0.03%8,199,893$799,325,570$898,708,273+$99,382,703+12.43%
Blackrock, Inc.0.01%4,123,822$401,990,169$451,970,891+$49,980,722+12.43%
State Street Corp0.01%2,357,440$229,798,634$258,375,424+$28,576,790+12.44%
Ra Capital Management, L.P.2.32%2,611,733$219,176,633$286,245,937+$67,069,304+30.60%
Wellington Management Group Llp0.04%2,595,783$217,838,110$284,497,817+$66,659,707+30.60%
Fairmount Funds Management Llc15.38%2,537,191$212,921,069$278,076,134+$65,155,065+30.60%
Vanguard Capital Management Llc0.00%2,159,568$210,514,689$236,688,653+$26,173,964+12.43%
Avidity Partners Management Lp41.81%2,104,184$184,747,355$230,618,566+$45,871,211+24.83%
Octagon Capital Advisors Lp18.08%1,946,667$163,364,295$213,354,703+$49,990,408+30.60%
Tcg Crossover Management, Llc4.03%1,676,624$140,702,286$183,757,990+$43,055,704+30.60%
Citadel Advisors Llc0.10%1,610,483$135,151,733$176,508,937+$41,357,204+30.60%
Geode Capital Management, Llc0.01%1,258,502$122,696,604$137,931,819+$15,235,215+12.42%
Ubs Group Ag0.02%1,140,260$111,152,545$124,972,496+$13,819,951+12.43%
Jennison Associates Llc0.06%1,021,763$99,601,453$111,985,225+$12,383,772+12.43%
Venrock Adviser, Llc3.70%1,180,000$99,025,600$129,328,000+$30,302,400+30.60%
Fred Alger Management, Llc0.43%1,161,923$97,508,578$127,346,761+$29,838,183+30.60%
Polar Capital Holdings Plc0.39%1,076,009$90,298,675$117,930,586+$27,631,911+30.60%
Deerfield Management Company, L.P.1.01%1,019,813$85,582,707$111,771,505+$26,188,798+30.60%
Cormorant Asset Management, Lp4.02%950,000$79,724,000$104,120,000+$24,396,000+30.60%
Braidwell Lp2.52%899,364$75,474,627$98,570,294+$23,095,667+30.60%
Baker Bros. Advisors Lp0.41%852,164$71,513,603$93,397,174+$21,883,571+30.60%
Farallon Capital Management Llc0.46%836,000$70,157,120$91,625,600+$21,468,480+30.60%
Vanguard Portfolio Management Llc0.00%570,115$55,574,810$62,484,604+$6,909,794+12.43%
Point72 Asset Management, L.P.0.09%643,599$54,010,828$70,538,450+$16,527,622+30.60%
Catalio Capital Management, Lp9.82%560,308$47,021,047$61,409,757+$14,388,710+30.60%
Goldman Sachs Group Inc0.01%548,010$45,988,999$60,061,896+$14,072,897+30.60%
Northern Trust Corp0.00%411,791$40,141,386$45,132,294+$4,990,908+12.43%
Balyasny Asset Management L.P.0.08%474,085$39,785,213$51,959,716+$12,174,503+30.60%
Affinity Asset Advisors, Llc1.91%400,000$38,992,000$43,840,000+$4,848,000+12.43%
Alliancebernstein L.P.0.01%926,071$38,163,386$101,497,382+$63,333,996+165.95%
Silverarc Capital Management, Llc4.23%390,000$38,017,200$42,744,000+$4,726,800+12.43%
Woodline Partners Lp0.14%433,457$36,375,711$47,506,887+$11,131,176+30.60%
Samlyn Capital, Llc0.62%431,115$36,179,171$47,250,204+$11,071,033+30.60%
Mpm Bioimpact Llc2.75%423,982$35,580,569$46,468,427+$10,887,858+30.60%
Spruce Street Capital Lp6.79%354,816$34,587,464$38,887,834+$4,300,370+12.43%
Logos Global Management Lp1.73%400,000$33,568,000$43,840,000+$10,272,000+30.60%
Barclays Plc0.01%379,606$31,856,536$41,604,818+$9,748,282+30.60%
Dimensional Fund Advisors Lp0.01%321,503$31,334,301$35,236,729+$3,902,428+12.45%
Sio Capital Management, Llc4.48%370,045$31,054,176$40,556,932+$9,502,756+30.60%
Westfield Capital Management Co Lp0.10%314,914$30,697,817$34,514,574+$3,816,757+12.43%
Bain Capital Life Sciences Investors, Llc2.74%362,470$30,418,482$39,726,712+$9,308,230+30.60%
Ameriprise Financial Inc0.01%358,470$30,082,981$39,288,312+$9,205,331+30.60%
Vivo Capital, Llc2.48%353,998$29,707,512$38,798,181+$9,090,669+30.60%
Vanguard Fiduciary Trust Co0.01%302,482$29,485,945$33,152,027+$3,666,082+12.43%
Assenagon Asset Management S.A.0.04%280,649$27,357,665$30,759,130+$3,401,465+12.43%
Driehaus Capital Management Llc0.20%317,312$26,628,823$34,777,395+$8,148,572+30.60%
Charles Schwab Investment Management Inc0.00%305,440$25,632,525$33,476,224+$7,843,699+30.60%
Artisan Partners Limited Partnership0.04%258,269$25,176,062$28,306,282+$3,130,220+12.43%
Bank Of New York Mellon Corp0.00%256,393$24,993,153$28,100,673+$3,107,520+12.43%
Emerald Advisers, Llc0.57%247,805$24,156,031$27,159,428+$3,003,397+12.43%

Frequently asked questions about DNTH

  • Who owns the most DNTH stock?

    The largest holders of DNTH are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for DIANTHUS THERAPEUTICS INC (DNTH).

  • Is DNTH widely held by superinvestors?

    Many widely followed stocks like DNTH appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly DNTH is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.